drugset / Trial / NCT05085184
Study to Evaluate the Safety and PK of UI018
RandomizedCrossoverOpen-labelTreatment
Summary
This Study is to evaluate the safety and pharmacokinetics of a fixed dose combination formulation and co-administration.
Timeline
- Start
- 2021-09-06
- Primary completion
- 2021-11-30
- Completion
- 2022-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UI018 | Unknown | — | — |
| Comparator | UIC201602 | Unknown | — | — |
| Comparator | UIC201806 | Unknown | — | — |